Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ted Wun

Showing results (131-140 of 141) with videos related to

Pageof 15
Sort By:
Thrombosis and Haemostasis|September 22, 2017
Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer: Rationale and Design of the CASSINI Trial. Rationale and Design of the CASSINI TrialAlok A Khorana, Saroj Vadhan-Raj, Nicole M Kuderer, et al.
Journal of Hematology & Oncology|February 19, 2013
A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell diseaseTed Wun, Denis Soulieres, Andrew L Frelinger, et al.
JCO Oncology Practice|January 6, 2022
Impact of COVID-19 on Hematology-Oncology Trainees: A Quantitative and Qualitative AssessmentUrshila Durani, Ajay Major, Ana I Velazquez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2003
SU5416 plus interferon alpha in advanced renal cell carcinoma: a phase II California Cancer Consortium Study with biological and imaging correlates of angiogenesis inhibitionPrimo N Lara, David I Quinn, Kim Margolin, et al.
Transplantation and Cellular Therapy|November 19, 2023
Comparison of Vital Status, Cause of Death, and Follow-Up after Hematopoietic Cell Transplantation in Linked Center for International Blood and Marrow Transplant Research and California Cancer Registry Data, 1991 to 2018Bryan Valcarcel, Sara J Schonfeld, Christa L Meyer, et al.
Leukemia Research|June 23, 2022
Clinical experience with frontline Hyper-CVAD-based regimens, including Hyper-CVAD plus ponatinib, in patients with acute lymphoblastic leukemia treated at a comprehensive cancer centerTamer Othman, Benjamin N Moskoff, Gwendolyn Ho, et al.
Blood|August 18, 2022
A randomized clinical trial of the efficacy and safety of rivipansel for sickle cell vaso-occlusive crisisCarlton D Dampier, Marilyn Jo Telen, Ted Wun, et al.
Blood Advances|June 12, 2024
Cumulative incidence estimates for solid tumors after HCT in the CIBMTR and California Cancer RegistrySara J Schonfeld, Bryan Valcarcel, Christa L Meyer, et al.
The New England Journal of Medicine|February 21, 2019
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with CancerAlok A Khorana, Gerald A Soff, Ajay K Kakkar, et al.
Current Epidemiology Reports|September 13, 2023
Challenges and Opportunities of Epidemiological Studies to Reduce the Burden of Cancers in Young AdultsHazel B Nichols, Karen J Wernli, Neetu Chawla, et al.
Pageof 15

Showing results (131-140 of 141) with videos related to

Sort By:
Pageof 15
Thrombosis and Haemostasis|September 22, 2017
Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer: Rationale and Design of the CASSINI Trial. Rationale and Design of the CASSINI TrialAlok A Khorana, Saroj Vadhan-Raj, Nicole M Kuderer, et al.
Journal of Hematology & Oncology|February 19, 2013
A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell diseaseTed Wun, Denis Soulieres, Andrew L Frelinger, et al.
JCO Oncology Practice|January 6, 2022
Impact of COVID-19 on Hematology-Oncology Trainees: A Quantitative and Qualitative AssessmentUrshila Durani, Ajay Major, Ana I Velazquez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2003
SU5416 plus interferon alpha in advanced renal cell carcinoma: a phase II California Cancer Consortium Study with biological and imaging correlates of angiogenesis inhibitionPrimo N Lara, David I Quinn, Kim Margolin, et al.
Transplantation and Cellular Therapy|November 19, 2023
Comparison of Vital Status, Cause of Death, and Follow-Up after Hematopoietic Cell Transplantation in Linked Center for International Blood and Marrow Transplant Research and California Cancer Registry Data, 1991 to 2018Bryan Valcarcel, Sara J Schonfeld, Christa L Meyer, et al.
Leukemia Research|June 23, 2022
Clinical experience with frontline Hyper-CVAD-based regimens, including Hyper-CVAD plus ponatinib, in patients with acute lymphoblastic leukemia treated at a comprehensive cancer centerTamer Othman, Benjamin N Moskoff, Gwendolyn Ho, et al.
Blood|August 18, 2022
A randomized clinical trial of the efficacy and safety of rivipansel for sickle cell vaso-occlusive crisisCarlton D Dampier, Marilyn Jo Telen, Ted Wun, et al.
Blood Advances|June 12, 2024
Cumulative incidence estimates for solid tumors after HCT in the CIBMTR and California Cancer RegistrySara J Schonfeld, Bryan Valcarcel, Christa L Meyer, et al.
The New England Journal of Medicine|February 21, 2019
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with CancerAlok A Khorana, Gerald A Soff, Ajay K Kakkar, et al.
Current Epidemiology Reports|September 13, 2023
Challenges and Opportunities of Epidemiological Studies to Reduce the Burden of Cancers in Young AdultsHazel B Nichols, Karen J Wernli, Neetu Chawla, et al.
Pageof 15